Gene Therapy Market Scope And Analysis

  • Report Code : TIPHE100001165
  • Category : Biotechnology
  • No. of Pages : 150
Buy Now

Gene Therapy Market Analysis, Trends, and Scope 2021 to 2022

Buy Now


Gene Therapy Market Report Scope

Report Attribute Details
Market size in 2023 US$ 5.11 Billion
Market Size by 2031 US$ 25.69 Billion
Global CAGR (2023 - 2031) 14.3%
Historical Data 2021-2023
Forecast period 2023-2031
Segments Covered By Vectors
  • Non-Viral Vectors and Viral Vectors
By Indication
  • Neurological Diseases
  • Cancer
  • Duchenne Muscular Dystrophy
  • Hepatological Diseases
  • Other Indications
By Delivery Mode
  • In-Vivo and Ex-Vivo
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Novartis AG
  • Astellas Pharma Inc
  • Bristol Myers Squibb Company
  • Bluebird Bio Inc
  • Sanofi
  • F Hoffmann La Roche Ltd
  • Daiichi Sankyo
  • CSL Behring
  • Biogen
  • Industry Developments and Future Opportunities:

    A few initiatives taken by market players operating in the global gene therapy market are listed below:

    • In January 2022, Ori Biotech Ltd secured over US$ 100 million in an oversubscribed Series B funding round to introduce an innovative cell and gene therapy manufacturing platform in the market.
    • In January 2020, Astellas Pharma Inc. acquired Audentes Therapeutics, Inc. The acquisition enables the combined company to become a global leader in AAV-based genetic medicine.

    Competitive Landscape and Key Companies:

    The gene therapy market forecast can help stakeholders plan their growth strategies. Novartis AG, Astellas Pharma Inc., Bristol-Myers Squibb Company, Bluebird Bio Inc., CSL Behring, Sanofi, F. Hoffmann-La Roche Ltd, Daiichi Sankyo, Biogen, and Oxford Biomedica are among the prominent players profiled in the gene therapy market report. These companies focus on introducing new high-tech products, advancements in existing products, and geographic expansions to meet the growing consumer demand worldwide.